Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Christopher Pasquale maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $110 to $120.
Barclays analyst Christopher Pasquale maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $110 to $120.